Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.

about

Baseline and post prophylactic tubal-ovarian surgery CA125 levels in BRCA1 and BRCA2 mutation carriers.

Item

http://www.wikidata.org/entity/Q38175815

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Baseline and post prophylactic ...... 1 and BRCA2 mutation carriers.

@en

type

Item

label

Baseline and post prophylactic ...... 1 and BRCA2 mutation carriers.

@en

prefLabel

Baseline and post prophylactic ...... 1 and BRCA2 mutation carriers.

@en

P1476

Baseline and post prophylactic ...... 1 and BRCA2 mutation carriers.

@en

P2093

Audrey Arden-Jones

http://www.w3.org/2001/XMLSchema#string

Carrier Clinic Collaborators

http://www.w3.org/2001/XMLSchema#string

Emma Wakeling

http://www.w3.org/2001/XMLSchema#string

Sarah Thomas

http://www.w3.org/2001/XMLSchema#string

Sibel Saya

http://www.w3.org/2001/XMLSchema#string

Sue Ashley

http://www.w3.org/2001/XMLSchema#string

Susan Shanley

http://www.w3.org/2001/XMLSchema#string

Ying Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

Reactivity of a monoclonal antibody with human ovarian carcinoma

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

Progress and challenges in screening for early detection of ovarian cancer.

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer.

Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up.

Cancer Incidence in BRCA1 mutation carriers.

Clinical management of BRCA1 and BRCA2 mutation carriers.

Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations.

P2888

s10689-013-9697-9

P304

197-203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10689-013-9697-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rosalind Eeles

Elizabeth K. Bancroft

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046109354

http://www.w3.org/2001/XMLSchema#string

P698

24389956

http://www.w3.org/2001/XMLSchema#string